Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

Background It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely
used to treat COPD, increases the risk of fracture, particularly in women, in view of the …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …

Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

Background Previous studies have found an association between the use of inhaled
corticosteroids and fracture, but the extent to which this association is due to inhaled …

Abstract Treatment with systemic corticosteroids is known to increase the risk of fractures but
little is known of the fracture risks associated with inhaled corticosteroids. A retrospective …

Deleterious effect of oral corticosteroids on bone has been well documented, whereas this
remains debated for inhaled ones (ICS). Our objectives were to analyze the effects of ICS on …

BACKGROUND The adverse effects of oral corticosteroids are widely recognised but there
are few quantitative data on which to base advice to patients. In a two part cross sectional …

Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …